128 related articles for article (PubMed ID: 11944335)
41. On the need for, and the delivery of, cross-protective vaccines.
Spier RE
Vaccine; 2005 Mar; 23(17-18):2027-9. PubMed ID: 15755565
[TBL] [Abstract][Full Text] [Related]
42. Identification of the types of adenovirus isolates with monoclonal antibodies.
Lu JR; Fu WY; Cheng HJ; Chen SL; Guo HJ; Leng L; Wu YM; Chen YY; Qi YM
Chin Med J (Engl); 1989 Aug; 102(8):650-4. PubMed ID: 2517624
[TBL] [Abstract][Full Text] [Related]
43. [Isolation of monoclonal antibodies to horseradish peroxidase and their use in immunohistochemistry and immunoblotting].
Faerman AI; Chervonskiĭ AV; Chipysheva TA; Gel'shteĭn VI; Koliada AIu
Biull Eksp Biol Med; 1987 May; 103(5):631-4. PubMed ID: 3297191
[TBL] [Abstract][Full Text] [Related]
44. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
Yang C; Shi H; Zhou J; Liang Y; Xu H
Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
[TBL] [Abstract][Full Text] [Related]
45. [Preparation of anti-human retinoblastoma monoclonal antibody by solid tumor cell immunization and study on characteristics of its antigen].
Zhong X; Li Y; Ning B; Yan J; Li Y; Luo G; Lin J; Ying F; Feng G
Zhonghua Yan Ke Za Zhi; 2002 Nov; 38(11):691-4. PubMed ID: 12487903
[TBL] [Abstract][Full Text] [Related]
46. Characterization of Env antigenicity of feline foamy virus (FeFV) using FeFV-infected cat sera and a monoclonal antibody.
Phung HT; Tohya Y; Miyazawa T; Akashi H
Vet Microbiol; 2005 Apr; 106(3-4):201-7. PubMed ID: 15778026
[TBL] [Abstract][Full Text] [Related]
47. Hit-and-run neutralization of poliovirus.
Brioen P; Rombaut B; Boeyé A
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2495-9. PubMed ID: 2997379
[TBL] [Abstract][Full Text] [Related]
48. [Monoclonal anti-NSE-antibodies: purification, characterization, and immunoenzyme analysis].
Chekhonin VP; Gurina OI; Portnaia TS; Riabukhin IA; Shepeleva II
Vopr Med Khim; 2002; 48(5):477-84. PubMed ID: 12498090
[TBL] [Abstract][Full Text] [Related]
49. [Obtaining of new monoclonal antibodies against human immunoglobulins of class G, suitable for use in diagnostics of infectious diseases].
Halkin OIu; Nikolaienko IV; Raievs'ka HIe; Mykhaĭlenko LP; Kostenko OH; Spivak MIa
Mikrobiol Z; 2005; 67(6):40-8. PubMed ID: 16493884
[TBL] [Abstract][Full Text] [Related]
50. Genetic features of polioviruses isolated in Tunisia, 1991-2006.
Haddad-Boubaker S; Ben Yahia A; Bahri O; Morel V; Balanant J; Delpeyroux F; Triki H
J Clin Virol; 2008 Feb; 41(2):81-6. PubMed ID: 18023246
[TBL] [Abstract][Full Text] [Related]
51. Preparation of anti-idiotypic antibody against avian influenza virus subtype H9.
Li B; Peng J; Niu Z; Yin X; Liu F
Cell Mol Immunol; 2005 Apr; 2(2):155-7. PubMed ID: 16191424
[TBL] [Abstract][Full Text] [Related]
52. Rapid methods for identification of poliovirus isolates and determination of polio neutralizing antibody titers in human sera.
Di Lonardo A; Buttinelli G; Amato C; Novello F; Ridolfi B; Fiore L
J Virol Methods; 2002 Mar; 101(1-2):189-96. PubMed ID: 11849697
[TBL] [Abstract][Full Text] [Related]
53. Antibodies to poliovirus detected by immunoradiometric assay with a monoclonal antibody.
Spitz M; Fossati CA; Schild GC; Spitz L; Brasher M
J Virol Methods; 1982 Oct; 5(2):101-11. PubMed ID: 6296172
[TBL] [Abstract][Full Text] [Related]
54. Neutralization of poliovirus by antibody-mediated polymerization.
Brioen P; Dekegel D; Boeyé A
Virology; 1983 Jun; 127(2):463-8. PubMed ID: 6306919
[TBL] [Abstract][Full Text] [Related]
55. Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people.
Boot HJ; Sonsma J; van Nunen F; Abbink F; Kimman TG; Buisman AM
Vaccine; 2007 Jun; 25(24):4706-14. PubMed ID: 17482726
[TBL] [Abstract][Full Text] [Related]
56. [Antiviral effect of recombinant antibody to influenza virus HA antigen].
Yang G; Wang Y; Zhao X; Han F; Wu S; Hou Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):337-40. PubMed ID: 12665899
[TBL] [Abstract][Full Text] [Related]
57. Specific cytotoxic T cells eliminate cells producing neutralizing antibodies.
Planz O; Seiler P; Hengartner H; Zinkernagel RM
Nature; 2003 Nov; 426(6965):474. PubMed ID: 14647387
[No Abstract] [Full Text] [Related]
58. An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies.
Martin NC; Pardo J; Simmons M; Tjaden JA; Widjaja S; Marovich MA; Sun W; Porter KR; Burgess TH
J Virol Methods; 2006 Jun; 134(1-2):74-85. PubMed ID: 16417930
[TBL] [Abstract][Full Text] [Related]
59. Mapping of epitopes of VP2 protein of chicken anemia virus using monoclonal antibodies.
Wang X; Gao H; Gao Y; Fu C; Wang Z; Lu G; Cheng Y; Wang X
J Virol Methods; 2007 Aug; 143(2):194-9. PubMed ID: 17481740
[TBL] [Abstract][Full Text] [Related]
60. Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola.
Vinjé J; Gregoricus N; Martin J; Gary HE; Caceres VM; Venczel L; Macadam A; Dobbins JG; Burns C; Wait D; Ko G; Landaverde M; Kew O; Sobsey MD
J Infect Dis; 2004 Apr; 189(7):1168-75. PubMed ID: 15031784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
